Skip to main content

Company
History

Leadership

Clients and Collaborators

By the Numbers
Capabilities
Emmes - CRO

Specialties

Vaccines & Infectious Diseases

Ophthalmology

Clinical Neuroscience

Rare Disease

Cell & Gene Therapy

Government

Additional Specialties

Hematology

Oncology

Maternal & Child Health

Medical Devices

Clinical Services

Biostatistics

Clinical Data Management

Clinical Research Services

Clinical Trial Management

Global Regulatory Affairs

Pharmacovigilance & Medical Monitoring

Veridix - Tech & AI

eClinical Platform

EDC

Decentralized Clinical Trials

Health Navigator

RTSM

eCOA / ePRO

AI Agents

Biostats and Analysis Agent

Data Management Agent

Document Authoring

GlobalTrace

Analytics & Reporting

Clinical Pipelines

VERA
Resources
Newsroom

Blog
Careers
Contact
Contact Us

Locations

Breadcrumb

Emmes Group
News
Novel Stem Cell Therapy To Treat Central Retinal Vein Occlusion

Newsroom

Go back to Newsroom

Novel stem cell therapy to treat central retinal vein occlusion

02/07/2026

Article

Go back to Newsroom

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation

Company
Capabilities
- Emmes - CRO
- Veridix - Tech & AI
Resources
- Newsroom
- Blog
Careers
Contact
- Contact Us
- Locations

Copyright ©, The Emmes Company, LLC

Footer

Cookie Policy
External Privacy Notice
FCOI
Emmes EU-U.S. Data Privacy Framework
Purchasing Terms and Conditions
Terms of Use
ISO Certification